medicines for europe
0449.332.209 · rovalta.com · 26/09/2026
ACTIVE
medicines for europe
Financial year 2025 · Closed on 31/12/2025
Net result-972,9 k €-760,2 %over 1 year
Gross margin744,3 k €-55,4 %over 1 year
Equity2,5 M €-27,8 %over 1 year
Workforce18,0 ETP+20,0 %over 1 year
Overview
Identity
Source · BCE/KBOmedicines for europe is a International non-profit organization incorporated in 1992. Its main activity is: Libraries, archives, museums and other cultural activities. Its registered office is in Ixelles. It employs on average 18,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0449.332.209
- Incorporation
- 26/10/1992
- Legal form
- International non-profit organization
- Registered office
- Rue Capitaine Crespel 30 box A03
1050 Ixelles · BruxellesSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 18,0 ETP
Activities (NACE)
Joint committees (1)
- 200
Signals
Solid equityLow riskGood liquidityHealthy social debts
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 744,3 k € | -55.4% | 1,7 M € | -1.4% | 1,7 M € | +14.9% | 1,5 M € | -25.3% | 2 M € |
| EBITDA | -1 M € | -781% | 149,2 k € | -57.2% | 348,1 k € | +7.5% | 323,7 k € | -63.5% | 886,6 k € |
| Operating result | -1 M € | -984% | 117,3 k € | -62.5% | 313,2 k € | +4.4% | 300 k € | -65.2% | 862,8 k € |
| Net result | -972,9 k € | -760% | 147,4 k € | -56.6% | 339,4 k € | +19.2% | 284,7 k € | -66.7% | 854,4 k € |
| Balance sheet | |||||||||
| Equity | 2,5 M € | -27.8% | 3,5 M € | +4.4% | 3,3 M € | +11.3% | 3 M € | +10.5% | 2,7 M € |
| Total assets | 3,7 M € | -11.7% | 4,2 M € | +2.1% | 4,1 M € | +11.5% | 3,7 M € | +14.4% | 3,2 M € |
| Cash | 3,4 M € | -13.7% | 3,9 M € | +128% | 1,7 M € | -45.4% | 3,1 M € | +7.9% | 2,9 M € |
| Debts | 962,6 k € | +70.9% | 563,4 k € | -7.5% | 609 k € | +34.0% | 454,5 k € | +25.5% | 362,1 k € |
| Other | |||||||||
| Workforce | 18,0 ETP | +20.0% | 15,0 ETP | +1.4% | 14,8 ETP | +13.8% | 13,0 ETP | -7.1% | 14,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/202518 active · 111 ended
Active mandates
Anish MEHTA
ActiveChristos GALLIS
ActiveMichel NITKA
ActiveChristophe DELENTA
ActiveMarc CROUTON
ActiveArthur CWIOK
ActiveBork BRETTHAUER
ActiveElisabeth STAMPA JAGER
ActiveJean HERMANS
ActiveLucas SIGMAN
ActiveMarkus SIEGER
ActiveMartha CHRISTOPOULOU
ActiveMichele UDA
ActivePaul TREWELL
ActivePhilippe DRESCHLE
ActiveSteffen SALTOFTE
ActiveStephen EDER
ActiveTheodore TRYFON
ActiveEnded mandates
Christophe DELENTA
EndedMarc CROUTON
EndedElisabeth STAMPA JAGER
EndedElisabeth STAMPA JAGER
EndedOther companies at this address
Rue Capitaine Crespel 30 1050 Ixelles| Company | CBE no. |
|---|---|
L&B ASSOCIATES● Active | 0536.411.087 |
LT ADVICE● Active | 0650.807.444 |
MabMidi● Active | 0666.473.637 |
TRAFALGAR REAL ESTATE● Active | 0729.963.305 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 30/06/2025 | 24/06/2024 | 26/06/2023 | 13/07/2022 | 08/07/2021 |
| General meeting | 10/06/2026 | 25/06/2025 | 12/06/2024 | 14/06/2023 | 29/06/2022 | 08/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 10/06/2026 | 31/07/2026 | French | |
| Abridged model | 31/12/2024 | 25/06/2025 | 30/06/2025 | French | |
| Abridged model | 31/12/2023 | 12/06/2024 | 24/06/2024 | French | |
| Abridged model | 31/12/2022 | 14/06/2023 | 26/06/2023 | French | |
| Abridged model | 31/12/2021 | 29/06/2022 | 13/07/2022 | French | |
| Abridged model | 31/12/2020 | 08/06/2021 | 08/07/2021 | French | |
| Abridged model | 31/12/2019 | 17/06/2020 | 08/09/2020 | French | |
| Abridged model | 31/12/2018 | 12/06/2019 | 01/07/2019 | French | |
| Abridged model | 31/12/2017 | 13/06/2018 | 20/06/2018 | French | |
| Abridged model | 31/12/2016 | 14/06/2017 | 28/06/2017 | French | |
| Abridged model | 31/12/2015 | 08/06/2016 | 15/07/2016 | French | |
| Abridged model | 31/12/2014 | 09/06/2015 | 23/06/2015 | French | |
| Abridged model | 31/12/2013 | 25/06/2014 | 02/07/2014 | French | |
| Abridged model | 31/12/2009 | 02/06/2010 | 27/07/2010 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202518 active · 111 ended
Active mandates
Anish MEHTA
ActiveChristos GALLIS
ActiveMichel NITKA
ActiveChristophe DELENTA
ActiveMarc CROUTON
ActiveArthur CWIOK
ActiveBork BRETTHAUER
ActiveElisabeth STAMPA JAGER
ActiveJean HERMANS
ActiveLucas SIGMAN
ActiveMarkus SIEGER
ActiveMartha CHRISTOPOULOU
ActiveMichele UDA
ActivePaul TREWELL
ActivePhilippe DRESCHLE
ActiveSteffen SALTOFTE
ActiveStephen EDER
ActiveTheodore TRYFON
ActiveEnded mandates
Christophe DELENTA
EndedMarc CROUTON
EndedElisabeth STAMPA JAGER
EndedElisabeth STAMPA JAGER
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates22/05/2026DEMISSIONS, NOMINATIONS
- Mandates23/04/2025DEMISSIONS, NOMINATIONS
- Other12/09/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates08/05/2024DEMISSIONS, NOMINATIONS
- Mandates04/05/2022DEMISSIONS, NOMINATIONS
- Mandates27/08/2020DEMISSIONS, NOMINATIONS
- Mandates21/08/2018DEMISSIONS, NOMINATIONS
- Mandates02/02/2018DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-972,9 k €↓
- 2024Annual accounts 2024147,4 k €↓
- 2023Annual accounts 2023339,4 k €↑
- 2022Annual accounts 2022284,7 k €↓
- 2021Annual accounts 2021854,4 k €↑
- 2020Annual accounts 2020237,7 k €↑
- 2019Annual accounts 201942,3 k €↑
- 2018Annual accounts 201819,7 k €↑
- 2017Annual accounts 20175,9 k €↓
- 2016Annual accounts 2016284,5 k €↑
- 2015Annual accounts 2015-232,9 k €↓
- 2015Name changeMEDICINES FOR EUROPE
- 2014Annual accounts 2014-35 k €↓
- 2013Annual accounts 2013-24,9 k €↓
- 2009Annual accounts 2009209,5 k €
- 2009Name changeEuropean generic medicines Association
- 26/10/1992IncorporationInternational non-profit organization